Biographical Sketch
Betul Hatipoglu, MD, is a Staff member in the Department of Endocrinology, Diabetes and Metabolism at Cleveland Clinic's main campus, having accepted that appointment in 2008. Prior to that appointment, she was an assistant professor of medicine and medical director for pancreas and islet cell transplant program at the University of Illinois at Chicago for nearly eight years.
Her clinical interests include diabetes, thyroid disease in woman and pituitary and adrenal disorders and alternative medicine.
Dr. Hatipoglu received her medical degree from Istanbul Medical School. She completed an internal medicine residency and chief residency at Michael Reese-University of Illinois at Chicago and an endocrinology fellowship at the University of Illinois at Chicago.
For four consecutive year 2004, 2005, 2006 and 2007 she received the Excellence in teaching award from University of Illinois at Chicago department of medicine. Dr. Hatipoglu speaks three languages -- English, Turkish and French -- and is board-certified in internal medicine as well as endocrinology, diabetes and metabolism. She is a member of the Endocrine Society, American Diabetes Association, American College of Medicine and the American Association of Clinical Endocrinologists.
Specialty Interests
Adrenal disorders, Alternative medicine, Diabetes, diabetes and diabetes complications, diabetes mellitus, endocrine complications of pregnancy, endocrinology, general endocrinology, Hirsutism, including pituitary and adrenal diseases, insulin resistance and cardiovascular risk prevention, pituitary and adrenal disorders, pituitary disease, thyroid, thyroid cancers, thyroid disease, thyroid disorders, thyroid nodules, type 1 diabetes
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical education about recent
trends. The collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with which
they collaborate. The Cleveland Clinic requires its doctors
to approve the public disclosures of their scientific
collaborations with industry. As of 10/24/2008 the review
process regarding Dr. Hatipoglu’s disclosure had not been
completed. Patients should feel free to contact their doctor
about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation page.
